Active Vanin 2 (VNN2) Homo sapiens (Human) Active protein

FOAP-4; GPI-80; Pantetheinase; Vascular Non-inflammatory Molecule 2; Glycosylphosphatidyl inositol-anchored protein GPI-80

Add to Cart Distributors
Overview
Properties
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder, Purity > 90%
  • Isoelectric Point5.4
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Active Vanin 2 (VNN2) Packages (Simulation)
  • Active Vanin 2 (VNN2) Packages (Simulation)
  • APF570Hu01.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Activity test

Vanin-2 (VNN2) is a glycosylphosphatidylinositol (GPI)-anchored ectoenzyme that plays crucial roles in inflammation and oxidative stress responses. As a member of the vanin family, it exhibits pantetheinase activity, converting pantetheine into cysteamine and pantothenic acid (vitamin B5). VNN2 is highly expressed in immune cells, particularly neutrophils, where it modulates cellular adhesion and migration during inflammatory processes. Recent studies highlight its involvement in neutrophil recruitment to inflammatory sites and its potential as a biomarker for various inflammatory diseases. The enzyme's activity influences glutathione metabolism, thereby regulating redox homeostasis in immune responses.Besides,VNN2 directly binds to Integrin Beta 2 (CD18) on leukocytes, facilitating their adhesion and transendothelial migration during inflammation.Thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human VNN2 and recombinant human CD18. Briefly, VNN2 was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to CD18-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-VNN2 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 µL stop solution to the wells and read at 450/630nm immediately. The binding activity of recombinant human VNN2 and recombinant human CD18 was shown in Figure 1, the EC50 for this effect is 0.009 µg/mL.

Usage

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Recommend products